- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01218503
The Neural Correlates of Food Choice Decision-making in Obesity and Weight Loss (CHOICES)
July 25, 2013 updated by: Kathryn E. Demos, The Miriam Hospital
The Neural Correlates of Food Choice Decision-making in Obesity and Weight Loss (CHOICES)
This study is designed to determine whether obese, normal weight, and successful weight loss maintainers differ in their food choice decision-making and/or executive function, and whether participation in a behavioral weight loss program leads to neural and/or behavioral changes.
The investigators will examine behavioral performance on several tasks involving decision-making and self-control in conjunction with brain imaging data acquired during a food-choice decision-making task.
Participants enrolled in the behavioral weight loss program will also be assessed following the treatment.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Active, not recruiting
- Weight Control & Diabetes Research Center
-
Providence, Rhode Island, United States, 02903
- Recruiting
- Weight Control & Diabetes Research Center
-
Contact:
- Kathryn E Demos, PhD
- Phone Number: 401-793-8939
- Email: kathryn_demos@brown.edu
-
Principal Investigator:
- Kathryn E Demos, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 55 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- women, ages 35-55, who are either currently obese (BMI = 30-40 kg/m2), always normal weight (lifetime BMI < 25, NW) or successful weight loss maintainers who have lost 10% of their body weight and maintained that loss for at least 1 year (lifetime maximum BMI = 30-40 kg/m2)
Exclusion Criteria:
- weight loss medications, binge eating, standard MRI contraindications (e.g., metal implants, claustrophobia, pregnancy), left-handedness, food allergies, neurological or psychiatric conditions, including but not limited to schizophrenia, bipolar disorder, epilepsy, stroke and traumatic brain injury with loss of consciousness, and, among obese participants, inability to participate at two time points and lack of interest in participating in a behavioral weight loss trial
- serious current physical disease (e.g., heart disease and cancer) for which physician supervision of diet and exercise prescription is needed, physical problems that limit the ability to exercise, participation in a weight loss program in the last 2 months and intention to become pregnant in the next 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CHOICES - obese
behavioral weight loss treatment - overweight/obese females
|
Standard group behavioral weight loss treatment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
fMRI
Time Frame: pre- and post-treatment in obese group, single time point for SWLM and NW
|
pre- and post-treatment in obese group, single time point for SWLM and NW
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Behavioral data
Time Frame: pre- and post-treatment of obese group, single time point for SWLM and NW
|
pre- and post-treatment of obese group, single time point for SWLM and NW
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (Anticipated)
October 1, 2016
Study Completion (Anticipated)
October 1, 2016
Study Registration Dates
First Submitted
October 7, 2010
First Submitted That Met QC Criteria
October 8, 2010
First Posted (Estimate)
October 11, 2010
Study Record Updates
Last Update Posted (Estimate)
July 29, 2013
Last Update Submitted That Met QC Criteria
July 25, 2013
Last Verified
July 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BRAIN-T32
- K01DK090445 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on CHOICES - obese
-
Northeastern UniversityNational Institute of Nursing Research (NINR)CompletedRisk Behavior | HIV | Sexual Behavior | Chlamydia | Women's RoleUnited States
-
University of FloridaNational Human Genome Research Institute (NHGRI)Active, not recruitingSickle Cell Disease | Sickle Cell TraitUnited States
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Johns Hopkins UniversityNational Institute on Aging (NIA); Medstar Health Research InstituteCompleted
-
University of PrimorskaElettra Synchrotron TriesteCompletedAsymptomatic ConditionSlovenia
-
Yeditepe University HospitalCompletedObesity | Difficult Intubation
-
UConn HealthNational Institute of Environmental Health Sciences (NIEHS)Completed
-
University Hospital, CaenUniversity of Geneva, SwitzerlandUnknown
-
Mathematica Policy Research, Inc.University of OklahomaCompletedPregnancy | Sexually Transmitted InfectionsUnited States
-
Kocaeli UniversityCompleted